InvestorsHub Logo
Followers 229
Posts 14656
Boards Moderated 1
Alias Born 03/29/2014

Re: None

Thursday, 02/23/2023 1:59:14 PM

Thursday, February 23, 2023 1:59:14 PM

Post# of 698836
No big, but here's a tidbit that I found interesting.

The Brain Tumour Research Charity has been very supportive of DCVax-L, and interestingly, the Chair of its Advisory Board, Garth Cruickshank, was at one time, an investigator for the DCVax-L trial.

From the historical files for the trial on clinicaltrials.gov
United Kingdom, West Midlands
"Queen Elizabeth Hospital
[Recruiting]
Birmingham, West Midlands, United Kingdom, B15 2TH
Contact: Principal Investigator: Garth Cruickshank, Prof"

https://www.braintumourresearch.org/media/news/news-item/2021/07/31/innovative-medicines-fund-announced

"The Chair of the Brain Tumour Research Scientific and Medical Advisory Board (SMAB) Emeritus Professor of Neurosurgery, Garth Cruickshank feels that this IMF initiative appears to be very good news for brain tumour patients."



https://www.thebraintumourcharity.org/media-centre/news/research-news/trial-finds-dcvax-l-can-prolong-the-lives-of-those-living-with-a-glioblastoma/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News